Medication adherence and blood pressure control: a scientific statement from the American Heart Association

NK Choudhry, IM Kronish, W Vongpatanasin… - …, 2022 - Am Heart Assoc
The widespread treatment of hypertension and resultant improvement in blood pressure
have been major contributors to the dramatic age-specific decline in heart disease and …

Disparities in hypertension and cardiovascular disease in blacks: the critical role of medication adherence

KC Ferdinand, K Yadav, SA Nasser… - The Journal of …, 2017 - Wiley Online Library
Blacks are two to three times as likely as whites to die of preventable heart disease and
stroke. Declines in mortality from heart disease have not eliminated racial disparities …

Adherencia terapéutica: un problema de atención médica

JJ Ortega Cerda, D Sánchez Herrera… - Acta médica grupo …, 2018 - scielo.org.mx
Hoy en día, es ampliamente sabido que la falta de adherencia al tratamiento es la principal
causa de que no se obtengan todos los beneficios que los medicamentos pueden …

Primary prevention of ischaemic heart disease: populations, individuals, and health professionals

R Gupta, DA Wood - The Lancet, 2019 - thelancet.com
Ischaemic heart disease has a multifactorial aetiology and can be prevented from
developing in populations primordially, and in individuals at high risk by primary prevention …

Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics

NS Shah, R Molsberry, JS Rana, S Sidney, S Capewell… - bmj, 2020 - bmj.com
Objective To describe trends in the burden of mortality due to subtypes of heart disease from
1999 to 2018 to inform targeted prevention strategies and reduce disparities. Design Serial …

Medication adherence in hypertension

NR Poulter, C Borghi, G Parati, A Pathak… - Journal of …, 2020 - journals.lww.com
Suboptimal adherence to antihypertensive medication is a major contributor to poor blood
pressure control. Several methods, direct or indirect, are available for measuring adherence …

Hypertension in African Americans: advances in community outreach and public health approaches

DP Ferdinand, S Nedunchezhian… - Progress in cardiovascular …, 2020 - Elsevier
While there have been significant advances made towards controlling cardiovascular
disease (CVD) morbidity and mortality in recent decades, African-Americans continue to …

Inclisiran: a novel agent for lowering apolipoprotein B–containing lipoproteins

BA Warden, PB Duell - Journal of Cardiovascular Pharmacology, 2021 - journals.lww.com
Hypercholesterolemia is a leading cause of cardiovascular morbidity and mortality.
Accordingly, efforts to lower apolipoprotein B–containing lipoproteins in plasma are the …

Update on hypertension in African-Americans

C Maraboto, KC Ferdinand - Progress in cardiovascular diseases, 2020 - Elsevier
Uncontrolled hypertension (HTN) in the US is particularly prevalent and devastating among
black individuals, who disproportionately suffer the consequences of this condition to a …

Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials

AC Pinho-Gomes, L Azevedo, JM Ahn, SJ Park… - Journal of the American …, 2018 - jacc.org
Background: Despite the well-established benefits of secondary cardiovascular prevention,
the importance of concurrent medical therapy in clinical trials of coronary revascularization is …